Arda Therapeutics jobs
2 matches, filter-driven and evidence-linked.
Filters
0 active
Remote, hybrid, onsite
State
Shift type
Weekend work
Country
Cover letter
Assessment
Salary type
Equity type
Family-building benefits
Benefit evidence
-
Scientist, In Vitro Pharmacology
Arda Therapeutics - San Carlos, CA, San Carlos, California, United StatesIndexed from Ashby2w agoWhy we showed this
Description: "therapeutics"Description: "arda"+5
Scientist, In Vitro Pharmacology San Carlos, CA, San Carlos, California, United States About Arda Traditional pharmaceuticals modulate individual proteins and signaling pathways, aiming to nudge tissues and organs back toward health. But cells - not proteins - are the functional units of diseased tissue, and their behavior is governed by redundant networks that single-target drugs struggle to change. Arda Therapeutics offers a groundbreaking alternative: we target cells, not pathways. By depleting specific pathogenic cells that drive chronic diseases such as fibrosis and inflammation, we shut down the entire network of dysfunction at once, rather than blocking one of many redundant nodes. What makes this possible is an explosion of single-cell data. Arda's discovery engine integrates multi-modal single-cell, spatial, and genetic data to pinpoint pathogenic cell states and the surface markers that distinguish them from healthy cells with unprecedented precision. We engineer targeted biologics that eliminate only the harmful cells, sparing healthy tissue and opening the door to greater efficacy and episodic treatment. Backed by leading life-science and technology investors - and built by a team that blends computational biology, drug development, and cell-depletion expertise - Arda is defining a new domain of medicine for inflammatory and immunological diseases. The Role Arda is seeking an experienced, self-driven scientist to lead in vitro pharmacology projects focused on developing the next-generation of immune-targeting therapies. This individual will play a pivotal role in developing and executing in vitro / ex vivo immunological assays to assess the efficacy of our therapeutic assets, with a particular
-
Principal Scientist, Ex Vivo Pharmacology
Arda Therapeutics - San Carlos, CA, San Carlos, California, United StatesIndexed from Ashbyposted 45 days agoWhy we showed this
Description: "therapeutics"Description: "arda"+5
Principal Scientist, Ex Vivo Pharmacology San Carlos, CA, San Carlos, California, United States About Arda Traditional pharmaceuticals modulate individual proteins and signaling pathways, aiming to nudge tissues and organs back toward health. But cells - not proteins - are the functional units of diseased tissue, and their behavior is governed by redundant networks that single-target drugs struggle to change. Arda Therapeutics offers a groundbreaking alternative: we target cells, not pathways. By depleting the specific pathogenic cells that drive chronic diseases such as fibrosis and inflammation, we shut down the entire network of dysfunction at once, rather than blocking one of many redundant nodes. What makes this possible now is an explosion of single-cell data. Arda's discovery engine integrates multi-modal single-cell, spatial, and genetic data to pinpoint pathogenic cell states and the surface markers that distinguish them from healthy cells with unprecedented precision. We then engineer targeted biologics that eliminate only the harmful cells, sparing healthy tissue and opening the door to greater efficacy and episodic treatment. Backed by leading life-science and technology investors - and built by a team that blends computational biology, drug development, and deep cell-depletion expertise - Arda is defining a new domain of medicine for inflammatory and immunological diseases. The Role Arda is seeking an experienced, resourceful scientist to lead our Ex Vivo Pharmacology team. This individual will play a pivotal role in developing and executing ex vivo models to assess the efficacy of our therapeutic assets, with a particular emphasis on multispecific immune cell engagers.
-
Associate Director, Analytical Development & Quality Control
Entrada Therapeutics Inc - Boston, MAIndexed from Greenhouse Benefit evidence checked Nov 20, 2026 Comp disclosed in postingposted 80 days agoWhy we showed this
Employer: semantic matchEmployer: "therapeutics"+2
Unspecified Operations From the posting source - Director Plus From the posting source $172K-$202K From the posting source Inferred from posting Learning budget Equity Inferred from posting 401(k) reportedAssociate Director, Analytical Development & Quality Control Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are motivated, resourceful, and enthusiastic quality control lead excited to be a key contributor for the
-
Hematology Therapeutic Specialist (Michigan/Ohio)
Adc Therapeutics SA - Commercial Field Sales Team- Remote WorkerIndexed from Paylocity1w agoWhy we showed this
Description: "therapeutics"Employer: "therapeutics"+2
Remote From the posting source Healthcare From the posting source - Mid From the posting source Salary not disclosed EquityHematology Therapeutic Specialist (Michigan/Ohio) Commercial Field Sales Team- Remote Worker Transforming Cancer Therapy TogetherAt ADC Therapeutics, we are passionate about revolutionizing cancer treatm
- 3w ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Unspecified Healthcare From the posting source - Mid From the posting source Salary not disclosed EquityClinical Trial Associate Viking Therapeutics, Inc. The Clinical Trial Associate (CTA) will provide administrative support to the Clinical Operations Team in full
-
Hematology Therapeutic Specialist (South Texas)
Adc Therapeutics SA - Commercial Field Sales Team- Remote WorkerIndexed from Paylocity1w agoWhy we showed this
Description: "therapeutics"Employer: "therapeutics"+2
Remote From the posting source Healthcare From the posting source - Mid From the posting source Salary not disclosed EquityHematology Therapeutic Specialist (South Texas) Commercial Field Sales Team- Remote Worker Transforming Cancer Therapy TogetherAt ADC Therapeutics, we are passionate about revolutionizing cancer treatm
- posted 30 days ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Unspecified Operations From the posting source - Mid From the posting source Salary not disclosed EquityProgram Manager, CMC Viking Therapeutics, Inc. As Program Manager, CMC, you will drive the coordinated execution of Chemistry, Manufacturing, and Controls (C
- 4w ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Engineer, Device Development Viking Therapeutics, Inc. The Engineer of Device Development combines hands-on technical execution with ownership of the integrated devi
-
Engineer, Sterile Drug Product
Viking Therapeutics - Viking Therapeutics, Inc.Indexed from Paylocity4w agoWhy we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Engineer, Sterile Drug Product Viking Therapeutics, Inc. The Engineer of Sterile Drug Product provides strategic leadership and technical oversight for sterile injecta
- posted 51 days ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed EquityAssociate Medical Director Viking Therapeutics, Inc. The Associate Medical Director, Clinical Development supports medical direction, management, and review of cli
- 4w ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Unspecified Healthcare From the posting source - Director Plus From the posting source Salary not disclosed EquityDirector, Clinical Quality Viking Therapeutics, Inc. The Director, Clinical Quality will lead the Clinical Quality Assurance function and provide strategic leaders
- posted 88 days ago
Why we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Unspecified Legal From the posting source - Director Plus From the posting source Salary not disclosed EquityDirector, Regulatory Affairs Viking Therapeutics, Inc. The Director of Regulatory Affairs (RA Director) will manage, evaluate, and execute regulatory projects consis
-
Senior Director, Program Management
Viking Therapeutics - Viking Therapeutics, Inc.Indexed from Paylocityposted 56 days agoWhy we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Senior Director, Program Management Viking Therapeutics, Inc. As the Senior Director of Program Management at Viking, your primary responsibility will be to drive the plann
-
Lean & Manufacturing Engineering Manager
Emerson Electric - FIORENZUOLA D'ARDA, EMILIA ROMAGNA, ItalyIndexed from Oracle Recruiting Cloud Benefit evidence checked Nov 20, 20264w agoWhy we showed this
Description: "arda"Location: "arda"+2
Unspecified Engineering From the posting source - Senior From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedLean & Manufacturing Engineering Manager FIORENZUOLA D'ARDA, EMILIA ROMAGNA, Italy If you are a Lean & Manufacturing Engineering Manager professional looking for an opportunity to grow your career, Emerson has an exciting opportunity for you in Fiorenzuola, Italy. In this role, you will lead the development and execution of lean manufacturing strategies and manufacturing engineering initiatives that drive operational excellence, productivity, quality, safety, and continuous improvement across the site.
-
Senior Manager, Pre-Formulation and Formulation Development
Arvinas Inc - New Haven - CTIndexed from Greenhouse2 days agoWhy we showed this
Title: semantic matchRole: semantic match+1
Senior Manager, Pre-Formulation and Formulation Development New Haven - CT Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development. #TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give
-
Director/Senior Director, Preclinical Pharmacology/Toxicology
Viking Therapeutics - Viking Therapeutics, Inc.Indexed from Paylocityposted 48 days agoWhy we showed this
Description: "therapeutics"Employer: "therapeutics"+3
Director/Senior Director, Preclinical Pharmacology/Toxicology Viking Therapeutics, Inc. Viking Therapeutics is seeking an experienced and highly motivated Director or Senior Director, Preclinical Ph
-
Associate Medical Director
Akebia Therapeutics Inc - Waltham, Massachusetts, United StatesIndexed from Greenhouse Benefit evidence checked Nov 20, 2026 Comp disclosed in posting3w agoWhy we showed this
Employer: semantic matchEmployer: "therapeutics"+2
Unspecified Healthcare From the posting source - Director Plus From the posting source $220K-$272K From the posting source Equity Inferred from posting 401(k) reportedAssociate Medical Director Waltham, Massachusetts, United States Nearly 37 million Americans are currently affected by Chronic Kidney Disease. 37 million. At Akebia we take that number very seriously and every day we come to work, with the purpose of bettering the lives of each person impacted by kidney disease and the renal community that serves them. Our tenacious, passionate employees' challenge the status quo and work to develop unique therapeutics that have the potential to set new standards of care for people living with kidney disease. This is life-changing work, and we are all in, are you? Please note that our offices have recently relocated to Waltham, MA. We follow a flexible, “magnet not mandate” approach to in-office work, encouraging in-person collaboration and onsite engagement while supporting hybrid flexibility based on role and business needs. Job Summary: The Clinical Development department is responsible for the medical aspects of development activities, including clinical development plans (CDP) and clinical trials. The Associate Medical Director will contribute to the direction, planning, execution and medical oversight of clinical trials and aligned research activities for one or more clinical development programs. Additionally, he/she will be involved to a varying degree in the analysis and interpretation of data outputs. He/she participates in cross-functional teams to generate, deliver, and disseminate high-quality clinical data supporting overall product scientific and business strategy. Essential Functions & Duties - Contribute to the development and execution of clinical development strategies and plans in alignment with program objectives. - Impact the development, review,
-
Medicinal Chemistry Project Leader
Arvinas Inc - Remote, Hybrid, New Haven - CTIndexed from Greenhouseposted 49 days agoWhy we showed this
Title: semantic matchRole: semantic match+1
Hybrid - 2d office From the posting source Other - Mid From the posting source Salary not disclosed EquityMedicinal Chemistry Project Leader Remote, Hybrid, New Haven - CT Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development. #TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give
- posted 71 days ago
Why we showed this
Title: semantic matchApply link reachable when checkedBand 7 - therapeutic radiographer ESSEX Band 7 Therapeutic Radiographer - Essex Location: Essex Position: Band 7 Therapeutic Radiographer Hours: Full-time Start: Immediate We're currently looking for an experienced Band 7 Therapeutic Radiographer to join a busy radiotherapy service in Essex on a full-time basis, with an immediate start available . The ideal candidate will have strong experience across both pre-treatment and treatment , with experience working on either Varian or Elekta technology. The role Band 7 Therapeutic Radiographer Full-time hours Immediate start Based in Essex Pre-treatment and treatment responsibilities Experience with Varian or Elekta systems required Working within a busy, supportive radiotherapy team About you HCPC registered Therapeutic Radiographer Previous Band 7-level experience preferred Confident working across both pre-treatment and treatment Experience using Varian or Elekta technology Available to start at short notice If you're a Therapeutic Radiographer currently available for a new opportunity in Essex, or you know someone who may be suitable, please get in touch for more information. Apply today to discuss the role and rates.
-
Senior Director of Large & Small Molecules & Biologics
Arvinas Inc - Remote, Hybrid, New Haven - CTIndexed from Greenhouse2 days agoWhy we showed this
Title: semantic matchRole: semantic match+1
Hybrid - 2d office From the posting source Other - Staff Plus From the posting source Salary not disclosed EquitySenior Director of Large & Small Molecules & Biologics Remote, Hybrid, New Haven - CT Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development. #TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue
- posted 36 days ago
Why we showed this
Title: semantic matchApply link reachable when checkedLead Therapeutic Radiographer London Band 7 Therapeutic Radiographer - 3-Month Contract | Norwich We are currently looking for an experienced Band 7 Therapeutic Radiographer to join a team in Norwich on an initial 3-month agency contract . This is a great opportunity for a suitably experienced Therapeutic Radiographer with strong clinical skills and experience in online image review and matching, alongside the ability to support and supervise junior colleagues. Key requirements: HCPC registration as a Therapeutic Radiographer. Minimum of 2 years' therapeutic radiography experience. Competent in online image review and online image matching. Experience supervising and supporting junior Therapeutic Radiographers. NHS experience is preferred, although candidates with equivalent experience in the private sector or overseas are encouraged to apply. Previous experience using Varian TrueBeam linear accelerators would be advantageous. Contract details: Location: Norwich Duration: Initial 3-month contract Level: Band 7 equivalent If you're an experienced Therapeutic Radiographer looking for your next contract opportunity, please get in touch to discuss the role in more detail.
-
Principal Scientist I, Biologics Analytical R&D (External Programs)
AbbVie Inc. - North Chicago, IL, United StatesIndexed from Smartrecruiters Benefit evidence checked Nov 20, 2026posted 191 days agoWhy we showed this
Title: semantic matchRole: semantic match+1
Unspecified Other - Staff Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedPrincipal Scientist I, Biologics Analytical R&D (External Programs) North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: Overview: AbbVie Biologics Analytical Research & Development (Biologics ARD) is a global analytical sciences organization responsible for CMC analytical activities related to the development of AbbVie's therapeutic biologic products. Our scope includes AbbVie's diverse pipeline of innovative therapeutic biologics medicines, including monoclonal antibodies, antibody drug conjugates (ADC), and other novel modalities, and spans from the selection of Discovery candidate molecules through the transition of analytical methods and testing to operations partners for late stage development. We are building a world-class team of scientists and leaders who will drive the advancement of industry-leading analytical capabilities and make meaningful contributions to advance AbbVie's pipeline of innovative medicines. Careers in AbbVie Biologics ARD provide unique opportunities to work with global and cross-functional teams to drive exceptional science and innovative product development strategies. The Analytical Development - External Programs group within Biologics ARD is responsible for early development (through clinical proof of concept) of programs with outsourced analytical activities.
-
Principal Scientist I, Biologics Analytical Research and Development
AbbVie Inc. - South San Francisco, CA, United StatesIndexed from Smartrecruiters Benefit evidence checked Nov 20, 20264 days agoWhy we showed this
Description: semantic matchDescription: "therapeutics"+2
Unspecified Other - Principal From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedPrincipal Scientist I, Biologics Analytical Research and Development South San Francisco, CA, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: About the Team AbbVie Biologics Analytical Research & Development (Biologics ARD) is a global analytical sciences organization responsible for CMC analytical development of AbbVie's pipeline of innovative therapeutic biologic products. We are a world-class team of scientists and leaders united by a shared mission to advance industry-leading analytical capabilities and meaningfully contribute to the advancement of AbbVie's pipeline of innovative medicines. The Biologics ARD team at the AbbVie Bay Area site in South San Francisco has a long and rich history of biologics development. Located in a state-of-the-art facility housing end-to-end CMC development capabilities, the team works collaboratively to advance novel biologic therapeutics - including multi-specifics, ADCs, antibodies, and novel modalities - into first-in-human clinical development and through to clinical proof of concept. Careers in AbbVie Biologics ARD provide unique opportunities to work with cross-functional and global teams to drive exceptional science and innovative product development strategies. Role Summary We are seeking a highly
-
Director, Biologics Analytical Development R&D
AbbVie Inc. - North Chicago, IL, United StatesIndexed from Smartrecruiters Benefit evidence checked Nov 20, 20264 days agoWhy we showed this
Title: semantic matchRole: semantic match+1
Unspecified Other - Director Plus From the posting source Salary not disclosed Equity Inferred from posting 401(k) reportedDirector, Biologics Analytical Development R&D North Chicago, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: The Biologics Analytical R&D (ARD) group supports innovative and unique early-stage biologics pipeline which includes mAbs, Bi- and multi-specifics, antibody drug conjugates (ADCs), Antibody Oligonucleotide Conjugates (AOCs), tLNPs, peptides and other biologic medicines. The team develops analytical methodologies and provides support to drug substance and drug product process and formulation development for traditional, high concentration, and complex formulations. Biologics ARD partners with all functions across Biologics CMC to deliver high-quality drug products for patients. The Director, Biologics ARD will lead an Analytical Development Early Phase group within AbbVie's Lake County (North Chicago headquarters) site. He/she will have accountability for multiple pipeline projects, development of relevant science and technology, people management, and implementation of functional strategies. He/she will ensure that the team's deliverables are completed within established timelines, budgets, resource allocation and in accordance with regulatory, quality, and safety requirements. The Ideal Candidate Will: Use a breadth of experience to drive phase-appropriate analytical development strategies to support AbbVie's early
Take this list with you
Download the 2 matching jobs in any format - read offline, archive, or hand to an AI assistant with your resume to find the best fits.
Or email it to me instead
The AI-ready prompt is a pre-written question you can paste into Claude, ChatGPT, Gemini, or Perplexity along with your resume. We never see your resume; this happens in your AI client of choice.
AI agent reading directly? Same data lives at /api/jobs.json?q=Arda+Therapeutics.
See /llms.txt and /api/openapi.json for the full schema.